J. V. Ponce

Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair.

William B. Downs, K. Blum, P. Thanos, 2019, Current pharmaceutical biotechnology.

In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.

K. Blum, T. Simpatico, R. Badgaiyan, 2020, Current psychopharmacology.

Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) During Adolescent Brain Development.

K. Blum, P. Thanos, T. Simpatico, 2021, Current psychopharmacology.

Precision Behavioral Management (PBM): A Novel Genetically Guided Therapy to Combat Reward Deficiency Syndrome (RDS) Relevant to the Opiate Crisis

K. Blum, P. Thanos, T. Simpatico, 2020 .

High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial

K. Blum, P. Thanos, J. Cadet, 2021, Molecular Neurobiology.

The Cambridge Handbook of Substance and Behavioral Addictions

Derek D. Reed, Mariel S. Bello, Derek T. Y. Mann, 2020 .